Clinical Trials Browser

Phase 2 × Adenocarcinoma Of Esophagus × regorafenib × Clear all

NCT02234180 2018-10-17

Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery

Phase 2 Terminated

3 enrolled 5 charts

Gastrointestinal

Adenocarcinoma Of Esophagus